Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINMON-J
NCT06953479Phase 4Recruiting
- Sponsor
- Lifespan Biotech
- Start
- Jun 2025
- Primary completion
- Jan 2027
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of velpatasvir in hepatitis C (HCV), sponsored by Lifespan Biotech. Started Jun 2025; status: recruiting.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT06953479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06953479.